French Scientist Says He Has Found COVID-19 Treatment

A French scientist says he has found an effective treatment for the coronavirus with “spectacular results” showing that “we know how to cure the illness”.

The treatment named Plaquenil is believed to be based on chloroquine, a drug normally used to treat malaria and professor Didier Raoult, who initiated the project, pitted two groups of 12 coronavirus patients against each other in the tests.

The first group of 12 patients received the treatment and the second was a control group.

Credit: Newsflash
Didier Raoult making a statement about the new treatment

Raoult, said the results are encouraging, explaining: “We were able to observe that 90 percent of the patients who had not received Plaquenil were still carriers after six days, whereas when you used Plaquenil, after six days, there are only 25 percent of carriers left.”

Didier Raoult has said his “spectacular” results after having done tests on 24 patients, show that “we know how to cure the illness”.

At the end of Tuesday’s Council of Ministers, government spokesperson Sibeth Ndiaye said: “Professor Didier Raoult has indeed expressed his wish to have clinical trials. These are therapeutic trials that test a drug or a combination of drugs to cure the coronavirus.

“There is a clinical trial on 24 patients that has been carried out and that gives really promising results. And in agreement with professor Raoult, the Ministry of Health wanted us to be able to extend this clinical trial.

“It will be extended but in another hospital, with a team independent from that of professor Raoult in order to scientifically ensure that it works for a much larger number of patients because 24 patients is a fairly low number.”

Ndiaye went on: “We are not rushing to pharmacies to buy chloroquine now, because, when we take too much, we can have consequences that are not terrible. And because we don’t have scientific proof today that it works.”

Credit: Newsflash
Alexandre Bleibtreu recognises chloroquine’s effectiveness in treating covid-19

We have a promising start for the clinical trial carried out in Marseille, we are extending it because the scientific discipline wants an experience, to be valid, to be duplicated several times in order to be able to say that it works or that it does not work.”

The use of chloroquine against the coronavirus was reportedly criticised a few weeks ago but now seems to interest scientists again.

Epidemiologist Alexandre Bleibtreu at the Pitie-Salpetriere Hospital who had initially criticised the chloroquine treatment appears to have changed his mind.

He said: “I got wind of results that made me change my mind. It’s not the treatment that seems the most obvious. It worked in vitro but we didn’t have any in vivo data.

“The goal isn’t to be right, it’s to make our patients better.”

He goes on to say: “We’re going to start Plaquenil therapy with our COVID+ facility at Pitie. I love humour and criticising dogma. So I apply it to myself.

“I think I was wrong enough to become a ‘Chloroquinist’ of ‘Raoultian’ descent.

“Thank you, St Didier, for having opened the way for us, we’re only fools. On this point in any case and if the data is confirmed.”

Credit: Newsflash
Treating coronavirus with chloroquine would be effective

Alexandre Bleibtreu reports that the treatment has been at the Pitie-Salpetriere Hospital since Friday 13th March, on about fifty patients.

Professor Raoult has appealed to scientists to ask them to carry out a lot of tests, saying that countries smaller than France have done more tests.

Reports say chloroquine is already regularly used to fight malaria and is an inexpensive treatment.

Other tests will be carried out at Lille Hospital to confirm the results of Professor Raoult’s team.

To find out more about the author, editor or agency that supplied this story – please click below.
Story By: Ernest Bio BogoreSub-EditorJoseph Golder, Agency: Newsflash

The Ananova page is created by and dedicated to professional, independent freelance journalists. It is a place for us to showcase our work. When our news is sold to our media partners, we will include the link here.




We don’t spam! Read our privacy policy for more info.

Signup to our Newsletter